Taysha Gene Therapies

IPO

Taysha GTx

Taysha Gene Therapies was founded in 2020, is headquartered in Dallas, United States, lists 51–200 employees, and has $275.0M in recorded funding across 3 rounds.

Headquarters
Dallas, Texas
Employees
51–200
Founded
2020
Business Model
B2B
Total Funding
$275.0M
Last Round
$150.0M Venture RoundAug 2023
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 4 investors for this company. The full record is or through the API.

About

Taysha Gene Therapies is a clinical-stage biotechnology company focused on developing AAV-based gene therapies for severe monogenic diseases of the central nervous system. Its lead program TSHA-102 targets Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies. Founded in 2020 and headquartered in Dallas, Texas, the company's management team has proven experience in gene therapy development and commercialization.

Summary

Taysha Gene Therapies is a Biotech company based in Dallas, United States, founded in 2020. It lists 51–200 employees. It has raised $275.0M in total across 3 rounds, most recently a $150.0M Venture Round in Aug 2023. Investors include Fidelity Management, GV and BlackRock.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Venture RoundPrivate PlacementAug 2023
$150.0M

Sign up to see all 4 events

Funding: Seed through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Taysha Gene Therapies on Indexed.vc
<a href="https://indexed.vc/companies/taysha-gene-therapies"><img src="https://indexed.vc/api/badge/company/taysha-gene-therapies" alt="Taysha Gene Therapies on Indexed.vc" width="260" height="76" /></a>